Recent Posts
- New Publication Further Validates SeptiCyte® RAPID for Disease Severity Assessment and Triaging in COVID-19 Patients with Extensive Lung Injury
- New Publication Validates SeptiCyte® RAPID as a Triaging Tool for COVID-19 Patients
- New Publication Validates SeptiCyte® RAPID as a Triaging Tool for COVID-19 Patients
- Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test
- At AMP 2022, Immunexpress launches rapid test for sepsis requiring two minutes hands-on time